Could ditching routine premeds boost chemo Patients' Well-Being?

NCT ID NCT07478315

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether breast cancer patients can safely stop taking allergy-preventing medications before weekly paclitaxel after two doses without a reaction. Researchers want to see if stopping these drugs improves quality of life, since they can cause side effects like insomnia and fatigue. The study will compare two groups of 50 patients: one that continues premedication and one that stops after two safe doses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.